Bahlmann Edda, Nienaber Christoph A, Cramariuc Dana, Gohlke-Baerwolf Christa, Ray Simon, Devereux Richard B, Wachtell Kristian, Kuck Karl Heinz, Davidsen Einar, Gerdts Eva
Asklepios Clinic St. Georg, Department of Cardiology, Hamburg, Germany.
Eur J Echocardiogr. 2011 Aug;12(8):585-90. doi: 10.1093/ejechocard/jer037. Epub 2011 Apr 19.
To report aortic root geometry by echocardiography in a large population of healthy, asymptomatic aortic stenosis (AS) patients in relation to current vendor-specified requirements for transcatheter aortic valve implantation (TAVI).
Baseline data in 1481 patients with asymptomatic AS (mean age 67 years, 39% women) in the Simvastatin Ezetimibe in AS study were used. The inner aortic diameter was measured at four levels: annulus, sinus of Valsalva, sinotubular junction and supracoronary, and sinus height as the annulo-junctional distance. Analyses were based on vendor-specified requirements for the aortic root geometry for current available prostheses, CoreValve and Edwards-Sapien. The ratio of sinus of Valsalva height to sinus width was 1:2. In multivariate linear regression analysis, larger sinus of Valsalva height was associated with older age, larger sinus of Valsalva diameter, lower ejection fraction and smaller supracoronary diameter (multiple R(2) = 0.19, P< 0.01). The required annulus diameter for implantation of CoreValve was met in 61.9%, and for the Edwards-Sapien prosthesis in 66.9%. Overall, annular dimension feasible for TAVI using any available prosthesis was found in 78.2% of patients and in 77.7% of patients also the required minimum sinus of Valsalva height was found. Comparing the group of patients who met TAVI requirements to those who did not, the latter included more women and patients with lower body height and weight and significantly smaller aortic root diameters (all P < 0.05).
Among AS patients in the SEAS study, 27% of women and 19% of men did not have aortic root geometry fulfilling current requirements for TAVI.
通过超声心动图报告大量健康无症状主动脉瓣狭窄(AS)患者的主动脉根部几何形态,以了解其与目前导管主动脉瓣植入术(TAVI)供应商指定要求的关系。
使用辛伐他汀依折麦布治疗AS研究中1481例无症状AS患者(平均年龄67岁,39%为女性)的基线数据。在内主动脉的四个水平测量内径:瓣环、主动脉窦、窦管交界和冠状动脉上,窦高度为瓣环与交界的距离。分析基于目前可用假体CoreValve和Edwards-Sapien对主动脉根部几何形态的供应商指定要求。主动脉窦高度与窦宽度之比为1:2。在多变量线性回归分析中,较大的主动脉窦高度与年龄较大、主动脉窦直径较大、射血分数较低和冠状动脉上直径较小相关(多重R² = 0.19,P < 0.01)。61.9%的患者满足CoreValve植入所需的瓣环直径,66.9%的患者满足Edwards-Sapien假体植入所需的瓣环直径。总体而言,78.2%的患者使用任何可用假体进行TAVI的瓣环尺寸可行,77.7%的患者也达到了所需的最小主动脉窦高度。将满足TAVI要求的患者组与不满足要求的患者组进行比较,后者包括更多女性以及身高和体重较低且主动脉根部直径明显较小的患者(所有P < 0.05)。
在SEAS研究的AS患者中,27%的女性和19%的男性主动脉根部几何形态不符合目前TAVI的要求。